Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To explore whether the patients with prostate cancer have functional changes in specific brain areas and changes in psychological and mental characteristics compared with the patients without prostate cancer.
This study was intended to observe the functional changes of brain fMRI in patients with and without prostate cancer enrolled in the cohort of patients who planned to undergo prostate biopsy, in an attempt to discover specific brain region changes in patients with prostate cancer, and lay a foundation for further clarifying the relationship and mechanism between brain region function changes and prostate cancer.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Prostate cancer group | Prostate cancer was confirmed by biopsy, and fMRI examination 、Zung Self Rating Anxiety Scale and Beck Depression Inventory-II were performed in these patients within 1 week before biopsy . |
| |
| Non-Prostate cancer group | Non-Prostate cancer was confirmed by biopsy, and fMRI examination 、 Zung Self Rating Anxiety Scale and Beck Depression Inventory-II were performed in these patients within 1 week before biopsy . |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| functional magnetic resonance imaging examination、Zung Self Rating Anxiety Scale and Beck Depression Inventory-II | Diagnostic Test | fMRI examination 、Zung Self Rating Anxiety Scale and Beck Depression Inventory-II were performed in these patients within 1 week before biopsy . |
| Measure | Description | Time Frame |
|---|---|---|
| The evaluation of Magnetic Resonance(MR) | To compare the differences in rs-fMRI measures (Amplitude of low frequency fluctuations , Regional Homogeneity and Functional Connectivity ) between prostate cancer group and Non-prostate cancer group. | Within 1 week before biopsy |
| Measure | Description | Time Frame |
|---|---|---|
| Assessment of anxiety status | Zung Self Rating Anxiety Scale was used to assess anxiety status.By comparing the final score, less than or equal to 10 is considered healthy, and more than 10 is considered abnormal. | Within 1 week before biopsy |
| Assessment of depressive status |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
The patient coming to our hospital for prostate biopsy and fully understand the clinical trial protocol and sign informed consent
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Shuaidong Wang | Contact | 15102100859 | wangshuaidong_wsd@163.com | |
| Haifeng Wang | Contact | 13681750891 | 446720864@qq.com |
| Name | Affiliation | Role |
|---|---|---|
| Haifeng Wang | Shanghai East Hospital of Tongji University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Shanghai East Hospital, Tongji University School of Medicine | Recruiting | Shanghai | Shanghai Municipality | 200120 | China |
Once available, the results of this trial will be disseminated to an international peer-reviewed journal and presentations at international or national academic conferences. The data will be made available upon request to researchers a) who provide a methodologically sound proposal and b) whose proposed use of the data has been approved by an independent ethical review committee.
Data will become available after publication with no end date
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D011471 | Prostatic Neoplasms |
| ID | Term |
|---|---|
| D005834 | Genital Neoplasms, Male |
| D014565 | Urogenital Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
Beck Depression Inventory-II was used to assess depressive status.By comparing the final scores, a score of 50 or less is considered healthy and a score of 50 or more is considered abnormal. |
| Within 1 week before biopsy |
| D005832 |
| Genital Diseases, Male |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
| D011469 | Prostatic Diseases |
| D052801 | Male Urogenital Diseases |